Abstract
Mintel last reported on the market for cold and flu remedies and decongestants in December 2006, since which time the market has continued to increase in value, despite a decline in the incidence of cold and flu and a dampening effect on the market from the rising uptake of the flu jab.
Over the last two years, the market has shown strong growth, driven by value-added products, favourable weather conditions and strong demand for decongestants. Major brands such as Lemsip, Beechams and Vicks command high levels of loyalty, but retailers' own-label products are increasing their presence in the market.
Main report themes
- All-in-one remedies vs specialisation
- Use of decongestants to treat hayfever
- Prevention vs. treatment
- Competition from general analgesics.
View Cart
